MetaCap

Upstream Bio (UPB) News

NASDAQ: UPBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.59-0.41 (-20.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

UPB news summary

We found 2 recent headlines mentioning Upstream Bio (UPB): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. UPB is making an outsized move today, down 20.50% at $1.59, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Upstream Q3 Loss Widens On Higher R&D Costs; Two Phase 2 Verekitug Readouts Due In H2 2027", was published by Nasdaq on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Upstream Bio headlines

Stocks mentioned alongside UPB

Compare UPB